Access to medicines
International standards & introductory material on access to medicines: click here
Articles & reports from a range of sources are below.
Related stories and components
EU: Commission launches public consultation on institutional investors & asset managers' duties regarding sustainability, incl. human rights
Author: European Commission
Author: David Gelles, Landon Thomas Jr., Andrew Ross Sorkin & Kate Kellyaug, NY Times (USA)
On Tuesday, Indra Nooyi, the chief executive of PepsiCo, joined a call with other prominent corporate chieftains who...had agreed to advise...Trump. A rebellion was brewing. Along with other business leaders, [she]...watched with bafflement over the...
- Related stories: Merck, Intel, Under Armour, Alliance for American Manufacturing & AFL-CIO resign from manufacturing council following President Trump's response to white supremacist violence in Charlottesville
- Related in-depth areas: CEO activism and other positive business initiatives to protect civic freedoms
- Related companies: General Motors IBM Intel Merck PepsiCo Under Armour
Author: Sarah Neville, Financial Times (UK)
The UK drugs industry is going to court in an attempt to stop the country’s taxpayer-funded National Health Service from imposing new limits on the price it will pay for medicines. The action follows a government crackdown in April that limits funding...
Author: Ram Etwareea, Le Temps (Suisse)
« Novartis attaque la Colombie en justice », 23 mai 2017...
- Related companies: Novartis
Colombia: Leaked documents reveal Novartis threatened govt. with intl. investment arbitration over licensing of pharmaceutical patents
Author: Public Eye
"Compulsory licensing in Colombia: Leaked documents show aggressive lobbying by Novartis", 11 Apr 2017...
Commentary: Embracing access to medicines can be beneficial for pharmaceutical companies' business & reputation
Author: Damiano de Felice, Access to Medicines Index, on Harvard Business Review
"How Pharma Can Fix Its Reputation and Its Business at the Same Time", 3 Feb 2017...
Author: Lydia Ramsey, Business Insider (UK)
"The makers of insulin are being accused of price-fixing in a class-action lawsuit", 30 Jan 2017...
Author: Grupo de Trabalho sobre Propriedade Intelectual-GTPI (Brazil)
“INPI rejeita pedido de patente do Truvada® no Brasil-Com a decisão, a combinação de medicamentos que atua na prevenção do HIV passa a fazer parte do domínio público”, 24 de janeiro de 2017...
- Related companies: Gilead Sciences